Most adults need two or three doses of hepatitis B vaccine, spread over one to six months depending on which vaccine is used. Once you complete the full series, you’re typically protected for life, and most healthy people never need a booster. The specifics depend on your age, which vaccine product you receive, and whether you have certain health conditions.
The Standard Adult Schedule
Adults aged 19 through 59 are recommended to get a hepatitis B vaccine series if they haven’t already been vaccinated. This became a universal recommendation from the CDC’s Advisory Committee on Immunization Practices in 2022, meaning it applies to all adults in that age range, not just those with specific risk factors. If you’re 60 or older and have risk factors for hepatitis B (like diabetes, sexual exposure, or working in healthcare), you should also get vaccinated. Anyone 60 or older can request the series even without risk factors.
The number of doses depends on the vaccine product:
- Two-dose series: Two shots given at least 4 weeks apart. This option uses a newer vaccine called Heplisav-B, which contains a stronger immune-stimulating ingredient and gets the job done in fewer visits.
- Three-dose series: Shots at 0, 1, and 6 months. This is the traditional schedule used by several vaccine products. The minimum spacing is 4 weeks between the first and second doses, 8 weeks between the second and third, and at least 16 weeks between the first and third.
- Four-dose accelerated series: A combination hepatitis A and B vaccine can be given on a faster timeline: three doses at day 0, day 7, and days 21 to 30, followed by a booster at 12 months. This schedule is useful when you need protection quickly, such as before international travel.
What If You Started but Didn’t Finish?
If you got one or two doses years ago but never completed the series, you don’t have to start over. Pick up where you left off, spacing the remaining doses according to the minimum intervals above. Your immune system retains memory from earlier doses even if a long time has passed.
If you’re unsure whether you were vaccinated as a child or can’t find records, a blood test can check for antibodies. An antibody level of 10 mIU/mL or higher means you’re protected. If your level is below that, your provider will recommend completing or repeating the series.
Do You Need a Booster?
Most healthy people do not need a booster dose after completing the initial series. The CDC states this directly: boosters are often not necessary, and most healthy people can skip them entirely. Studies following vaccinated individuals for decades have found that immune protection persists long term, even after antibody levels naturally decline over time. Your immune system remembers the virus and can mount a rapid response if exposed, even years later.
The exceptions involve people whose immune systems don’t respond as strongly to the vaccine or whose immunity fades faster due to medical conditions.
Schedules for Dialysis and Immune Conditions
People on hemodialysis and those with weakened immune systems need higher doses and sometimes more shots, because their immune systems have a harder time building a strong response. Adults on hemodialysis typically receive either a four-dose series or a three-dose series using a special high-dose formulation that contains twice the standard amount of vaccine protein.
Adults aged 20 or older with immunocompromising conditions also have several options, including the two-dose Heplisav-B series at 0 and 1 month, a three-dose series at 0, 1, and 6 months using high-dose formulations, or a four-dose series at 0, 1, 2, and 6 months. The choice depends on the specific product and your provider’s assessment of your immune function.
Healthcare Workers and Post-Vaccination Testing
Healthcare workers are one of the few groups that should have their antibody levels checked after vaccination. Testing is recommended 1 to 2 months after the final dose in the series. If your antibody level comes back at 10 mIU/mL or higher, you’re considered immune, and you won’t need periodic retesting or boosters going forward.
If your antibodies fall below that threshold after completing the full series, you’ll be asked to go through a second complete vaccine series and then retest. A small percentage of people simply don’t respond well to the vaccine. Those who remain below 10 mIU/mL after two full series are classified as non-responders. They won’t receive additional vaccine, but if they’re exposed to hepatitis B through a needlestick or blood contact, they can receive a dose of hepatitis B immune globulin for immediate, temporary protection.
Infants and Children
Infants in the United States routinely receive hepatitis B vaccine starting at birth. The standard childhood series is three doses: the first at birth, the second at 1 month, and the third at 6 months. This has been part of the routine immunization schedule for decades and is one reason hepatitis B infection rates have dropped dramatically in younger age groups. If your child falls behind schedule, the same principle applies as with adults: there’s no need to restart the series, just resume with the remaining doses at appropriate intervals.
Choosing Between 2 and 3 Doses
For most adults without special health considerations, the practical choice comes down to convenience. The two-dose option means fewer appointments and a faster timeline, with the entire series finished in about a month. The three-dose option takes six months but uses vaccine products that have been available longer and cost less in some settings. Both provide equivalent long-term protection for healthy adults. One note: the combination hepatitis A/B vaccine and the newer PreHevbrio vaccine are not recommended during pregnancy due to limited safety data.
Whichever schedule you choose, completing the full series is the important part. A single dose provides some immune priming but not reliable long-term protection. Two doses of a three-dose product leaves you partially protected but still vulnerable. Finishing all doses in your chosen series is what builds the durable immunity that lasts for life.